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ABSTRACT 
 
Preeclampsia is the worldwide leading cause of fetomaternal morbidity and mortality which involves 
the placental dysfunction. A poor placentation and formed of non-dilated spiral artery caused utero-
placental circulation insufficiency, resulted in inadequate supply of nutrients and oxygen to support normal 
aerobic growth of the fetus. Apium graveolens or celery has been widely known as antioxidant, 
antiinflammation and antihypertensive with flavonoid-apigenin as main active compound. Apigenin can 
inhibit TNF-α, HIF-1α and nitric oxide blocking as major pathophysiological pathway of preeclampsia. This 
study was aimed to find how the Apium graveolens can improve intrauterine growth and its correlation with 
suppression of anti-angiogenic factor sFlt-1 in anti-Qa2 preeclampsia animal model. Twenty female BALB/c 
Mus musculus were divided into 4 groups: control, anti-Qa2 and anti-Qa2 with 500 and 1000 mg/kgBW 
celery herbs extract. The fetal weights and lengths, placental weights and serum sFlt-1 levels were measured 
and analyzed with One Way ANOVA and further tested with Least Significance Difference in 95% confidence 
interval. The result showed a difference between control and treatments group (p≤0.05) with 1000 mg/kgBW 
significantly increase intrauterine growth and decrease sFlt-1, then there is a negative correlation between 
intrauterine weight and serum sFlt-1. This study suggests that celery herbs extract (CHE) has an apigenin-
flavonoid compound which can prevent intrauterine growth restriction (IUGR) via suppression of 
antiangiogenic factor production in preeclampsia mice model. 
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INTRODUCTION 
Preeclampsia is present in 2%-8% 
pregnancies and one of the world leading cause of 
perinatal mortality and morbidity. In developing 
countries, almost ten percent maternal deaths 
incident is related to pregnancy hypertension 
with preeclampsia-eclampsia as the most major 
cause. Preeclampsia is referred to the disease of 
theories because the pathophysiology is not fully 
understood as many hypotheses have developed; 
placental vascularity abnormalities, placental 
ischemia, free radicals, endothelial dysfunction, 
immunological intolerance between mother and 
fetus, abnormal genetic cardiovascular adaptation, 
nutritional deficiency, and inflammatory theories 
(Ahmed, 2015; Powe, 2011; Steegers, 2010). 
Based on the high incidence mentioned above, 
World Health Organization in 2011 stated that 
optimizing health care to prevent and treat 
preeclampsia is still a necessary step toward 
development goals. Although the hypertension 
and proteinuria as the clinical manifestations have 
occurred in late second or third trimester of  
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pregnancy, the pathogenesis began in early 
pregnancy as formed of non-dilated spiral artery 
(Powe, 2011). 
Normal pregnancy requires immune-
maternal adaptation in NK cell activity for the 
trophoblast invasion (Lockwood, 2008). 
Imbalance between T helper CD4+ cell 
differentiation into Treg cells that induce 
immunologic tolerance and Th17 cells that cause 
inflammation or rejection reactions caused 
increasing inflammation cytokines; TNF-α and IL-
6. This immune-maladaptation caused inadequate 
tolerance, chronic inflammation and poor 
angiogenesis then disturbed trophoblast invasian 
and reduced placental blood flow which supply 
nutrients and oxygen to fetus (Saito, 2010; 
Santner-Nanan, 2009). Furthermore, placental 
development requires vasculogenesis and 
angiogenesis, then a progression imbalance of the 
vascular endothelial growth factor (VEGF), 
placenta growth factor (PIGF) and angiopoietin 
during placental development resulted in adaptive 
angiogenesis in IUGR placental villi. VEGF also has 
VEGF receptors VEGFR-1 and VEGFR-2, which 
soluble form of VEGFR-1 (soluble Fms-tyrosine 
like/sFlt-1) has a strong antagonistic activity and 
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neutralizes the effects mediated by VEGF and PlGF 
(Ahmed, 2000). The increase in sFlt-1 in 
preeclampsia is also caused by a response to 
hypoxia that also involves genetic and 
immunological factors. The increasing expression 
of sFlt-1 increases in response to hypoxia is 
mediated by hypoxia inducible factors 1-α (HIF-1 
α) and Angiotensin II type1-receptor autiantibodies 
(AT1-AA) (Herse, 2013; Maynard, 2011). 
Apium graveolens or Celery is a common 
plant which has active compounds with flavonoids 
apigenin and apiin as main contents. Apigenin in 
Celery has ability as an antioxidant, anti-
inflammatory (Kooti, 2017; Yao, 2010), 
antihypertensive (Jin, 2009; Zhang, 2002), 
antiischemic and antiarrhythmia (Occhiuto et al, 
1991). Apigenin extracted from celery herbs has 
been shown as endothelial nitric oxide synthase 
(eNOS) stimulator and able to inhibit HIF-1α 
expression as a factor causing placental hypoxia 
by blocking its interactions with HIF-1α-Hsp90 
receptors (Manolescu, 2009; Olszanecki, 2002). 
Yamagata (2011) also stated that the flavon 
structure and double bonding on C ring in 
apigenin content of herb celery extracts can cause 
binding of ROS through inhibition of Tumor 
Necrosis Factor (TNF) -α and lectinlike oxidized 
LDL receptor-1 (LOX -1). 
In recent few years, many studies reported 
the prevention and treatment with the compound 
which able to bind inhibit sFlt-1 production and 
restore the vasculogenesis and angiogenesis 
function, such as VEGF121 recombinant, xanthone 
in mangosteen peel and thymoquinone in black 
cumin extracts (Rahma, 2017; Sulistyowati, 2017; 
Hidayati, 2015). The objective of the present study 
was to investigate whether the actions of Apium 
graveolens compound can prevent intrauterine 
growth restriction with reducing sFlt-1 
production in preeclampsia animal model. 
 
METHODOLOGY 
Experimental Design and Sampling 
This study was an experimental study using 
completely randomized design with twenty 
healthy female BALB/c mice (Mus musculus) 
which bred and cared in the Faculty of Veterinary 
Medicine, Airlangga University. All samples were 
randomly divided into 4 groups: control group, 
anti-Qa2 group, anti-Qa2+CHE 500 mg/kgBW and 
anti-Qa2+1000 mg/kgBW.  The mice were housed 
in plastic cages with wooden chip bed in a 
temperature-controlled room (230 C), given food 
and water ad libitum, and exposed to a light-dark 
cycle of 12:12 hours as its cyrcadian rhythm. All 
protocols were approved by the Animal Care and 
Use Committee (ACUC), Faculty of Veterinary 
Medicine, Airlangga University No. 
2.KE.001.01.2018.  
 
Mating Procedure 
All samples were injected with 5 IU 
Pregnant Mare’s Serum Gonadotropin (PMSG PG 
600, MSD Animal Health, Intervet Inc.), followed 
by human Chorionic Gonadotropin (hCG Chorulon, 
MSD Animal Health, Intervet Inc.) fourty-eight 
hours later. This method was done for oestrus 
cycle synchronization and prepared for mating 
following the procedures by The Practice 
Committee of the American Society for 
Reproductive Medicine in 2008. After the injection 
of hCG, all samples were mated one-on-one with 
mature male mice (aged 7 months and weighed + 
40 g). The presence of sperm plug seventeen 
hours later considered as day 0 of gestations. 
 
Anti-Qa2 Injection 
The treatment group was injected with 
anti-Qa2 10 ng i.p. on 1-4 days of gestations which 
has known that the implantation occurred 
approximately in a first quarter of murine 
pregnancy (Sones, 2016). Injection of anti Qa2 use 
the previous protocols by Sulistyowati (2010) that 
Qa2 was expressed in fifth day of gestations in 
normal mice, then the absence with anti-Qa2 
injection i.v. has led to increasing of Heat Shock 
Protein (HSP-70) and Vascular Cell Adhesion 
Molecule-1 (VCAM-1) in preeclampsia. The 
previous study used the intravenous injection 
then we modify to intraperitoneal injection as it 
has similar efficient bioavailibility as i.v. which is 
impractical and at risk of mice perivascular 
trauma. Turner, et al (2011) in Journal of the 
American Association for Laboratory Animal 
Science also stated that intravenous injection 
routinely and has potential for severe 
complications, including blindness, 
cerebrovascular stroke, permanent motor deficits, 
and limb gangrene. Most previous preeclampsia 
animal model studies also used the 
intraperitoneal injection, such as TNF-α injection 
and human preeclampsia serum injection 
(Wicaksono, 2015; Kalkunte, 2010). 
 
Celery Herbs Extraction and Treatment 
Sterilized and shade air-dried Apium 
graveolens herbs were extracted with 70% 
ethanol maceration methods in the Phytochemical 
Laboratory of Materia Medica, Batu, Indonesia. 
Powdered celery herbs were soaked and shaked 
in ethanol 70%, then filtered with filtration cloth. 
Filtrate were extracted for second and third time 
with additional solvent. The combined filtrate 
then evaporated and suspended in Na CMC 0.5% 
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suspending agent to a final concentration before 
use. The extracted celery herbs injected in 
treatment group in 6-15th days of gestations as 
known in mid-first trimester until third trimester. 
 
Measurement of Results 
Samples Termination 
All samples were terminated on the 16th 
day of gestations as the third trimester of 
pregnancy which reflects the time preeclampsia 
onset (Sulistyowati, 2017). The surgical 
procedure was performed under general 
anesthesia using intramuscular injection of 
ketamine. Then, the number of fetus, any fetus 
with resorption and placental weight were 
measured. Each newborn fetus was weighed using 
analytical instruments and the lengths were also 
measured and documented. 
Serum sFlt-1 
Mice blood was directly taken from the 
right heart then centrifuged at 6000 rpm for 10 
minutes. Serum was taken and measured the sFlt-
1levels using ELISA kit (Bioassay Technology 
Laboratory, China, catalog number E0611Mo) and 
ELISA reader 450 nm wavelength.  
 
Statistical Analysis 
Collected data were tested with Shapiro-
Wilk normality test and Lavene homogenity test. If 
the data were normal and homogeneous (P≥0.05), 
these were continued with 5% One Way ANOVA 
analysis and further tested with LSD (Least 
Significance Difference) 5% if there are significant 
differences (P≤0.05). Both intrauterine growth 
and serum sFlt-1 also tested with Pearson 
correlation test. 
 
RESULT AND DISCUSSION 
A graveolens in Fetal and Placental Growth 
Anti Qa-2 group injection had lower the 
number of fetus born compared to normal group. 
Anti Qa-2 also increased the number of fetal 
resorption and reduced other characteristics as 
fetal weight, fetal length and placental weight. 
Anti Qa-2 caused growth restriction as normal 
fetuses (0.233 + 0.18 g) which bigger than anti Qa-
2 injection group (0.792 + 0.32 g) (see Table 1.), 
then celery herbs extract injection in both 500 
mg/kgBW and 1000 mg/kgBW show increasing of 
number of fetus, fetal weight (0.432 + 0.19 g and 
0.472 + 0.07 g), fetus length and placental weight 
(0.114 + 0.30 and 0.129 + 0.11), followed by 
reducing the number of number of fetus with 
resorption with P=0.00 as significant difference in 
all of groups. In this study, we assumed that fetal 
growth restriction was symmetrically indicated by  
shorter fetal length in anti Qa-2 group which was 
11.129 mm compared to normal group which was 
23.038 mm (P-value=0.000≤0.05), then celery 
herbs extract increasing fetus length as 13.830 
mm in 500 mg/kgBB CHE and 15.818 mm in 1000 
mg/kgBB CHE. 
The growth restriction due to anti Qa-2 
injection as compared to preeclampsia might be 
caused by hypoxia while ischemia was caused by 
reduced placental blood flow. Previous studies 
using the same haplotype of mice showed that Qa-
2 is a murine homolog of Human Leukocyte 
Antigen-G (HLA-G) as non-classical Class Ib Major 
Histocompatibility Complex (MHC) located in Q 
region (Q6, Q7,Q8, and Q9) (Da Silva, 2017). HLA-
G regulation has been widely reported as the pre-
implantation embryonic development gene which 
plays an important role as Killer Inhibitory 
Receptor (KIR) ligand for maternal NK cell. The 
dysregulation of human leukocyte antigen (HLA)-
G was found in both placentas and maternal sera 
from preeclampsia patients (Tang, 2015; Djurisic, 
2014; Durmanova, 2013). The disruption of 
placental development led to limited 
cytotrophoblast invasion of the arteries in the 
superficial decidua and the myometrial segments 
remained narrow and undilated (Maynard, 2011). 
The intrauterine growth restriction (IUGR) 
defined as is defined as a rate of fetal growth that 
is less than normal for the growth potential of a 
specific infant as per the race and gender of the 
fetus. The IUGR in preeclampsia is caused by 
maternal factor as preeclampsia is the disease 
with the effect on blood circulation, resulted in 
decrease in uteroplacental blood flow and lead to 
IUGR (Sharma, 2016). The placental factor in 
preeclampsia IUGR involved the decrease of 
terminal villi number and surface area which 
shows a malfunction of vascularization in 
pregnancy. As mentioned before, the adequate 
trophoblast invasion and an increase in 
uteroplacental blood flow is required with 
increase in gestation to meet the demand of 
growing fetus (Zygmunt, 2003). The intrauterine 
growth restriction caused by anti Qa-2 injection 
was also significantly shown (P-
value=0.000≤0.05) which reduced placental 
weight (0.085 + 0.05 g) compared to normal 
group (0.150 + 0.03 g). 
According to Cunningham (2014), placental 
dysfunction in preeclampsia is indicated by the 
miointima cells proliferation and tunica media 
necrosis. This mechanism started with lipids that 
accumulate in miointima cells and subsequently  
in macrophages and caused atherosis and 
uteroplacental blood flow disruption.  
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Furthermore, celery has been commonly known 
to have antihypertensive effects through 
antioxidant-relaxation dependent pathway, 
increased nitric oxide (NO) and antiproliferation 
of vascular smooth muscle (Jorge, 2013; Jin, 2009; 
Zhang, 2002). This effect was shown to increase 
placental blood flow, as indicated by the increased 
placental weight of the anti-Qa2 group 0.085 + 
0.05 g to 0.114 + 0.30 g and 0.129 + 0.11 g in the 
celery group 500 and 1000 mg/kgBW, followed by 
the increased of fetal weight.  
 
Apium graveolens in sFlt-1 Serum Levels 
Figure 1 shows that anti-Qa2 group having 
higher serum sFlt-1 levels than control (p ≤0.05), 
then the anti-Qa2 group with the treatment of 500 
celery herbal extracts and 1000 mg/kgBW show 
decreased sFlt-1 levels. In addition, at the sFlt-1 
level in the group with the CHS treatment 1000 
mg/kg BW did not differ statistically with the 
control group (p≥ 0.05). Celery has been known to 
inhibit the increase of TNF-α and HIF-1α which 
are the activation paths of AT1-AA which causes 
an increase in sFlt-1. This sFlt-1 supression by 
celery restores the VEGF angiogenesis function, 
decreases the clotting factor and restores the 
endothelial function to improve the blood flow to 
the placenta (Yamagata, 2011; Manolescu, 2009). 
This effect has been proved with Pearson 
correlation test among sFlt-1 levels, fetal weights, 
fetal lengths, placental weights which shows that 
sFlt-1 has strong negative correlation with each 
intrauterine growth characteristic (P≤0.05). These 
results indicated that the decrease of sFlt-1 by 
celery caused an increase in the growth of fetus 
and placenta. 
Table II shows that sFlt-1 has negative 
correlation to fetal weight, fetal length and 
placental weight with high coefficient of Pearson 
correlation -0.648, -0.610, and -0.621 respectively. 
Herraiz (2015) has reviewed the role of sFlt-1 as 
angiogenesis-related biomarkers in placental 
dysfunction which resulted in inhibit intrauterine 
growth. sFlt-1 mRNA as alternative splicing of the 
Flt-1 gene has generated in response to hypoxia, 
then sFlt-1 is produced and secreted from the 
placenta to the maternal circulation, causing a 
reduction of the inhibition of proangiogenic 
factors. This mechanism will disrupt                              
the remodeling of the spiral arteries in their 
myometrial segments during normal pregnancy 
and regulation of the flow pressure to the 
intervillous space. This led to the appearance               
of         hypoperfusion-reperfusion        phenomena,  
 
 
Figure 1. Injection of anti Qa-2 resulted in increased of sFlt-1 compared to control group (*showed 
significantly different, p≤0.05), then 1000 mg/kgBW celery herbs extract reducing serum sFlt-1 which did 
not show significantly different with control group (p≥0.05). 
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then caused villous damage and an impairment of 
the maternal-fetal exchange, resulted in 
intrauterine growth restriction. Previous studies 
used the herbal product to preeclampsia 
treatment has done by Rahma (2017) which 
explained how the thymmoquinone in Nigella 
sativa decreased placental angiotensin II type 1-
receptor autoantibody (AT1-AA) serum levels and 
endothelin-1 (ET-1) expression. Hidayati (2015) 
also studied that mangosteen peel extract 
decreased Nf-κB, sFlt-1, TNF-α, blood pressure 
and proteinurine in preeclampsia. The herbal 
product with antioxidant and angiogenic ability 
could decrease sFlt-1, AT1-AA and increase VEGF 
and resulted in prevention of IUGR as explained in 
the studies by Sulistyowati (2017) and Soetrisno 
(2017) with recombinant VEGF and L-arginine 
injection.  
 
CONCLUSION 
This study suggests that herb celery extract 
in 1000 mg/kgBB can prevent intrauterine 
growth restriction via suppression of 
antiangiogenic factor production in preeclampsia 
mice model. The possible pathway is a celery 
apigenin-flavonoid compound which inhibit TNF-
α and HIF-1α actions. 
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